Pleasanton, California-based Spirosure (previously known as Spirometrix) has raised $15 million in Series C-2 financing for its breath analysis device, according to a statement. The funding round was led by returning investor NGK Spark Plugs Co. Ltd. of Japan, as well as other unnamed investors.
According to the statement, the money will be used to fund sales and regulatory processes in Europe,...
